Preventive aspirin treatment of streptozotocin induced diabetes: Blockage of oxidative status and revertion of heme enzymes inhibition

Some late complications of diabetes are associated with alterations in the structure and function of proteins due to glycation and free radicals generation. Aspirin inhibits protein glycation by acetylation of free amino groups. In the diabetic status, it was demonstrated that several enzymes of hem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Caballero, F.
Otros Autores: Gerez, E., Batlle, A., Vazquez, E.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2000
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 11837caa a22012977a 4500
001 PAPER-2339
003 AR-BaUEN
005 20230518203144.0
008 190411s2000 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0034213854 
024 7 |2 cas  |a Aspirin, 50-78-2; Blood Glucose; Catalase, EC 1.11.1.6; Enzyme Inhibitors; Hemoglobin A, Glycosylated; Hydroxymethylbilane Synthase, EC 2.5.1.61; Porphobilinogen Synthase, EC 4.2.1.24; Streptozocin, 18883-66-4 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a CBINA 
100 1 |a Caballero, F. 
245 1 0 |a Preventive aspirin treatment of streptozotocin induced diabetes: Blockage of oxidative status and revertion of heme enzymes inhibition 
260 |c 2000 
270 1 0 |m Batlle, A.Viamonte 1881 10 A, C1056ABA Buenos Aires, Argentina; email: batlle@mail.retina.ar 
506 |2 openaire  |e Política editorial 
504 |a Booth, A., Khalifah, R., Todd, P., Hudson, B., In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways (1997) J. Biol. Chem., 272, pp. 5430-5437 
504 |a Frye, E., Degenhardt, T., Thorpe, S., Baynes, J., Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins (1998) J. Biol. Chem., 273, pp. 18714-18719 
504 |a Brownlee, M., Lilly Lecture. Glycation and diabetes complications (1994) Diabetes, 43, pp. 836-841 
504 |a Loske, C., Neumann, A., Cunningham, A., Nichol, K., Schinzel, R., Riederer, P., Cytotoxicity of advanced glycation end products is mediated by oxidative stress (1998) J. Neural. Transm., 105, pp. 1005-1015 
504 |a Syrovy, I., Hodny, Z., In vitro non-enzymatic glycosilation of myofibrillar proteins (1993) Int. J. Biochem., 25, pp. 941-946 
504 |a Fu, M., Wells-Knecht, K., Blackledge, J., Lyons, T., Thorpe, S., Baynes, J., Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction (1994) Diabetes, 43, pp. 676-683 
504 |a Hunt, J., Bottoms, M., Mitchinson, M., Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation (1993) Biochem. J., 291, pp. 529-535 
504 |a Lal, S., Chithra, P., Chandrakasan, G., The possible relevance of autoxidative glycosylation in glucose mediated alterations of proteins: An in vitro study on myofibrillar proteins (1996) Mol. Cell. Biochem., 26, pp. 95-100 
504 |a Nagaraj, R., Shipanova, I., Faust, F., Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal (1996) J. Biol. Chem., 271, pp. 19338-19345 
504 |a Lisi, P., Santeusanio, F., Lombardi, G., Compagnucci, P., Carbohydrate metabolism in porphyria cutanea tarda (1983) Dermatologica, 166, pp. 287-293 
504 |a Fernandez-Cuartero, B., Rebollar, J., Batlle, A., Enriquez De Salamanca, R., Delta aminolevulinate dehydratase (ALA-D) activity in human and experimental diabetes mellitus (1999) Int. J. Biochem. Cell. Biol., 31, pp. 479-488 
504 |a Yalouris, A., Raptis, S., Effects of diabetes on porphyric attacks (1987) Br. Med. J., 295, pp. 1237-1241 
504 |a Sajithlal, G., Chithra, P., Chandrakasan, G., Advanced glycation end products induce cross-linking of collagen in vitro (1998) Biochim. Biophys. Acta, 1407, pp. 215-224 
504 |a Cherian, M., Abraham, E., In vitro glycation and acetylation (by aspirin) of rat crystallins (1993) Life Sci., 52, pp. 1699-1707 
504 |a Caballero, F., Gerez, E., Polo, C., Mompo, O., Vazquez, E., Shultz, R., Alteraciones en el camino metabólico del hemo en pacientes diabéticos (1995) Medicina, 55, pp. 117-124 
504 |a Polo, C., Vazquez, E., Gerez, E., Caballero, F., Batlle, A., STZ-induced diabetes in mice and heme pathway enzymes. Effect of allylisopropylacetamide and α-tocopherol (1995) Chem. Biol. Interact., 95, pp. 327-334 
504 |a Caballero, F., Gerez, E., Polo, C., Vazquez, E., Batlle, A., Reducing sugars trigger delta-aminolevulinic dehydratase inactivation: Evidence of in vitro aspirin prevention (1998) Gen. Pharmac., 31, pp. 441-445 
504 |a Parker, M., England, J., Da Costa, J., Hess, R., Goldstein, D., Improved colorimetric assay for glycosylated hemoglobin (1981) Clin. Chem., 27, pp. 669-672 
504 |a Batlle, A., Ferramola, A., Grinstein, M., Purification and general properties of δ-aminolevulinate dehydratase from cow liver (1967) Biochem. J., 104, pp. 244-249 
504 |a Chance, B., Maehly, A., Assay of catalase and peroxidases (1955) Methods in Enzimology, pp. 764-768. , E. Chance, & A. Maehly. New York: Academic Press 
504 |a Batlle, A., Wider, E., Stella, A., A simple method for measuring erythrocyte porphobilinogenase and its use in the diagnosis of acute intermittent porphyria (1978) Int. J. Biochem., 9, pp. 871-877 
504 |a Lowry, O., Rosebrough, N., Farr, A., Randall, R., Protein measurement with the Folin-phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275 
504 |a Niehaus, W., Samuelson, B., Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation (1968) Eur. J. Biochem., 6, pp. 126-130 
504 |a Swamy, M., Abraham, E., Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo (1989) Invest. Ophthalmol. Vis. Sci., 30, pp. 1120-1126 
504 |a Yue, D., McLennan, S., Handelsman, D., Delbridge, L., Reeve, T., Turtle, J., The effect of salicylates on nonenzymatic glycosylation and thermal stability of collagen in diabetic rats (1984) Diabetes, 33, pp. 745-751 
504 |a Woollard, A., Wolff, S., Bascal, Z., Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract (1990) Free Radic. Biol. Med., 9, pp. 299-305 
504 |a Schechter, Y., Perspectives in diabetes. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes (1990) Diabetes, 39, pp. 1-5 
504 |a Hoshi, A., Takahashi, M., Fujii, J., Myint, T., Kanto, H., Suzuki, K., Glycation and inactivation of sorbitol dehydrogenase in normal and diabetic rats (1996) Biochem. J., 318, pp. 119-123 
504 |a McCarthy, A., Cortizo, A., Gimenez Segura, G., Bruzzone, L., Etcheverry, S., Non-enzymatic glycosylation of alkaline phosphatase alters its biological properties (1998) Mol. Cell. Biochem., 181, pp. 63-69 
504 |a Bitar, M., Weiner, M., Diabetes-induced metabolic alterations in heme synthesis and degradation and various heme-containing enzymes in female rats (1984) Diabetes, 33, pp. 37-44 
504 |a Oxlund, H., Andreassen, T., Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus (1992) Diabetologia, 35, pp. 19-25 
504 |a Bastar, I., Seckin, S., Uysal, M., Aykac-Toker, G., Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats (1998) Res. Commun. Mol. Pathol. Pharmacol., 102, pp. 265-272 
504 |a Jordan, P., Biosynthesis of tetrapyrroles (1991) New Comprehensive Biochemistry Series, 19. , A. Neuberger, van Deemen L. Amsterdam: Elsevier 
504 |a Baynes, J., Role of oxidative stress in development of complications in diabetes (1991) Diabetes, 40, pp. 405-412 
504 |a Kakkar, R., Kalra, J., Mantha, S., Prasad, K., Lipid peroxidation and activity of antioxidant enzymes in diabetic rats (1995) Mol. Cell. Biochem., 151, pp. 113-119 
520 3 |a Some late complications of diabetes are associated with alterations in the structure and function of proteins due to glycation and free radicals generation. Aspirin inhibits protein glycation by acetylation of free amino groups. In the diabetic status, it was demonstrated that several enzymes of heme pathway were diminished. The aim of this work has been to investigate the in vivo effect of short and long term treatment with acetylsalicylic acid in streptozotocin induced diabetic mice. In both treatments, the acetylsalicylic acid prevented δ-aminolevulinic dehydratase and porphobilinogen deaminase inactivation in diabetic mice and blocked the accumulation of lipoperoxidative aldehydes. Catalase activity was significantly augmented in diabetic mice and the long term treatment with aspirin partially reverted it. We propose that oxidative stress might play an important role in streptozotocin induced diabetes. Our results suggest that aspirin can prevent some of the late complications of diabetes, lowering glucose concentration and probably inhibiting glycation by acetylation of protein amino groups. Copyright (C) 2000 Elsevier Science Ireland Ltd.  |l eng 
536 |a Detalles de la financiación: A. Batlle and E. Vazquez are members of the Career of Scientific Researcher at the Argentine National Research Council (CONICET). F. Caballero and E. Gerez hold the post of Research Assistant at the CONICET. This work has been supported by grants from the CONICET and the University of Buenos Aires, Argentina. We are very grateful to B. Corvalan for technical assistance. 
593 |a Department of Biological Chemistry, FCEN, Univ. Buenos Aires, Ctro. I., Buenos Aires, Argentina 
690 1 0 |a ACETYLSALICYLIC ACID 
690 1 0 |a EXPERIMENTAL DIABETES MELLITUS 
690 1 0 |a GLYCATION 
690 1 0 |a HEME ENZYMES INACTIVATION 
690 1 0 |a LIPID PEROXIDATION 
690 1 0 |a OXIDATIVE STRESS 
690 1 0 |a ACETYLSALICYLIC ACID 
690 1 0 |a CATALASE 
690 1 0 |a GLUCOSE 
690 1 0 |a HEME 
690 1 0 |a PORPHOBILINOGEN DEAMINASE 
690 1 0 |a PORPHOBILINOGEN SYNTHASE 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a ENZYME INACTIVATION 
690 1 0 |a GLYCATION 
690 1 0 |a LIPID PEROXIDATION 
690 1 0 |a LIVER 
690 1 0 |a MALE 
690 1 0 |a MOUSE 
690 1 0 |a NONHUMAN 
690 1 0 |a OXIDATIVE STRESS 
690 1 0 |a PROTEIN GLYCOSYLATION 
690 1 0 |a STREPTOZOCIN DIABETES 
690 1 0 |a ANIMALS 
690 1 0 |a ASPIRIN 
690 1 0 |a BLOOD GLUCOSE 
690 1 0 |a CATALASE 
690 1 0 |a DIABETES MELLITUS, EXPERIMENTAL 
690 1 0 |a DIET 
690 1 0 |a EATING 
690 1 0 |a ENZYME INHIBITORS 
690 1 0 |a HEMOGLOBIN A, GLYCOSYLATED 
690 1 0 |a HYDROXYMETHYLBILANE SYNTHASE 
690 1 0 |a LIPID PEROXIDATION 
690 1 0 |a MALE 
690 1 0 |a MICE 
690 1 0 |a OXIDATIVE STRESS 
690 1 0 |a PORPHOBILINOGEN SYNTHASE 
690 1 0 |a STREPTOZOCIN 
700 1 |a Gerez, E. 
700 1 |a Batlle, A. 
700 1 |a Vazquez, E. 
773 0 |d 2000  |g v. 126  |h pp. 215-225  |k n. 3  |p Chem.-Biol. Interact.  |x 00092797  |w (AR-BaUEN)CENRE-4162  |t Chemico-Biological Interactions 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034213854&doi=10.1016%2fS0009-2797%2800%2900168-X&partnerID=40&md5=2baa21645d2a97daf14f29cc4f296c1e  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/S0009-2797(00)00168-X  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00092797_v126_n3_p215_Caballero  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00092797_v126_n3_p215_Caballero  |y Registro en la Biblioteca Digital 
961 |a paper_00092797_v126_n3_p215_Caballero  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 63292